Cromolyn Sodium Inhalation
- Product NDC
- 48102-033
- 11-digit product format
- 481020033
- Labeler code
- 48102
- Product ID
- 48102-033_d4183942-25bb-4995-b514-06e277ee5448
- Type
- HUMAN PRESCRIPTION DRUG
- Nonproprietary name
- cromolyn sodium
- Dosage form
- SOLUTION
- Route
- INTRABRONCHIAL
- Labeler
- Fera Pharmaceuticals, LLC
- Application
- ANDA075437
- Marketing category
- ANDA
- Marketing start
- 2022-05-01
- Marketing end
- 0000-00-00
- Substance
- CROMOLYN SODIUM
- Active strength
- 20 mg/2mL
- Pharmacologic classes
- Decreased Histamine Release [PE], Mast Cell Stabilizer [EPC]
- NDC exclude flag
- No
- Listing certified through
- 2023-12-31
- Current FDA listing
- Historical FDA.report record
FDA-Initiated Inactive NDC Indexing#
Packages#
Package NDC, 11-digit format, Description table| Package NDC | 11-digit format | Description | Units | Marketing start | Marketing end | Sample | Exclude flag | Status |
|---|
| 48102-033-60 | 48102003360 | 5 POUCH in 1 CARTON (48102-033-60) > 12 VIAL, SINGLE-DOSE in 1 POUCH (48102-033-12) > 2 mL in 1 VIAL, SINGLE-DOSE | 5 pouch | 2022-05-01 | 0000-00-00 | No | No | Current |